European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 4.750
+0.250 (5.54%)
Oct 9, 2025, 4:45 PM CET
EBR:ALEMS Market Cap
EBR:ALEMS has a market cap or net worth of €20.10 million as of October 9, 2025. Its market cap has decreased by -29.72% in one year.
Market Cap
20.10M
Enterprise Value
36.53M
Revenue
49.47M
Ranking
n/a
PE Ratio
17.14
Stock Price
€4.75
Market Cap Chart
Since May 11, 2016, EBR:ALEMS's market cap has decreased from 86.09M to 20.10M, a decrease of -76.65%. That is a compound annual growth rate of -14.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 20.10M | -20.83% |
| Dec 31, 2024 | 25.39M | -27.47% |
| Dec 29, 2023 | 35.01M | -57.73% |
| Dec 30, 2022 | 82.82M | 1,588.91% |
| Dec 31, 2021 | 4.90M | 0.90% |
| Dec 31, 2020 | 4.86M | -28.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 48.24B |
| argenx SE | 41.55B |
| Financière de Tubize | 10.33B |
| Fagron NV | 1.45B |
| Ion Beam Applications | 326.03M |
| Onward Medical | 224.32M |
| Nyxoah | 209.27M |
| Hyloris Pharmaceuticals | 173.60M |